Orexo announces new US patent for ZUBSOLV®

Corporate Breaking News

Home : Orexo announces new US patent for ZUBSOLV®

Dec 30 2020	Orexo announces new US patent for ZUBSOLV®
UPPSALA, Sweden, Dec. 30, 2020 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the US Patent and Trademark Office has issued an additional patent for ZUBSOLV®, Orexo's sublingual buprenorphine and naloxone tablet (CII) for the treatment of opioid use...


Source:https://www.prnewswire.com:443/news-releases/orexo-announces-new-us-patent-for-zubsolv-301199255.html

Related News
» Announcement of change in the total number of votes in AB SKF » European Datawarehouse Submits Application to FCA to be Registered as a UK Securitisation Repository